Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chordomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Early research (Phase 1)Study completedNCT04246671
What this trial is testing

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Who this might be right for
ChordomaHER2-positive Breast Cancer
Bavarian Nordic 37
Testing effectiveness (Phase 2)Study completedNCT03623854
What this trial is testing

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Who this might be right for
ChordomaLocally Advanced ChordomaMetastatic Chordoma+1 more
Jonsson Comprehensive Cancer Center 10
Not applicableStudy completedNCT02520128
What this trial is testing

IMRT in Primary Bone and Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma, AdultEwing SarcomaBone Sarcoma+1 more
University College, London 191
Early research (Phase 1)Ended earlyNCT02936102
What this trial is testing

FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerChordoma and Alveolar Soft Part Sarcoma
Novartis Pharmaceuticals 154
Testing effectiveness (Phase 2)Active Not RecruitingNCT00496119
What this trial is testing

Proton Beam Therapy for Chordoma Patients

Who this might be right for
Chordoma
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)UnknownNCT06140732
What this trial is testing

Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma

Who this might be right for
ChordomaChemotherapy Effect
Xuanwu Hospital, Beijing 30
Large-scale testing (Phase 3)UnknownNCT01182779
What this trial is testing

Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base

Who this might be right for
ChordomaTumorTreatment
Heidelberg University 319
Not applicableLooking for participantsNCT06029218
What this trial is testing

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy

Who this might be right for
ChordomaChondrosarcomaEwing Sarcoma+1 more
Centre Antoine Lacassagne 106
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Early research (Phase 1)Ended earlyNCT04965753
What this trial is testing

FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors

Who this might be right for
Advanced Synovial Sarcoma
Foghorn Therapeutics Inc. 55
Early research (Phase 1)Ended earlyNCT05355753
What this trial is testing

Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors

Who this might be right for
Synovial SarcomaSoft Tissue Sarcoma
C4 Therapeutics, Inc. 49
Early research (Phase 1)Study completedNCT04670679
What this trial is testing

A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 90
Not applicableActive Not RecruitingNCT01200680
What this trial is testing

Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes

Who this might be right for
GenesSporadic Chordoma
National Cancer Institute (NCI) 188
Early research (Phase 1)Active Not RecruitingNCT02989636
What this trial is testing

Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma

Who this might be right for
Chordoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05041127
What this trial is testing

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Who this might be right for
ChordomaMetastatic ChordomaUnresectable Chordoma
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT02601950
What this trial is testing

Tazemetostat in Adult Participants With Soft Tissue Sarcoma

Who this might be right for
Malignant Rhabdoid Tumors (MRT)Rhabdoid Tumors of the Kidney (RTK)Atypical Teratoid Rhabdoid Tumors (ATRT)+8 more
Epizyme, Inc. 267
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Testing effectiveness (Phase 2)Looking for participantsNCT06794645
What this trial is testing

Pembrolizumab and Pemetrexed for Progressive Chordoma

Who this might be right for
ChordomasChordoma
Saint John's Cancer Institute 21
Not applicableLooking for participantsNCT03910465
What this trial is testing

Children and Adults With Chordoma

Who this might be right for
Chordoma
National Cancer Institute (NCI) 300
Next Page